| Through new drug launches, panel discussions, and similar forums. | Défense des droits des patients
> Médicaments et traitements associés | Partenariat réglementaire
> Travailler avec les organismes de réglementation | 1 000 | Regional | Sometimes | 115028447628 |
| Regular roundtables and forums are being held with the Ministry of Health and Welfare, the NHIS [국민건강보험공단 – National Health Insurance Service], HIRA [건강보험심사평가원 – Health Insurance Review and Assessment Service], the Korea Medical Research Institute, and other relevant bodies, with a view to improving the pharmaceutical pricing system. | Cancer
> Cancer : la plupart des types | Partenariat réglementaire
> Participer aux évaluations des technologies de santé (ETS) et aux examens de remboursement | 10 000 | National | Regularly | 114998266569 |
| We assess cost-effectiveness. | Foie
> Maladies du foie : la plupart des types | Partenariat réglementaire
> Participer aux évaluations des technologies de santé (ETS) et aux examens de remboursement | 100 000 | National | Sometimes | 114998327089 |
| We nominate patient group representatives as committee members on bodies such as the HIPDC [Health Insurance Policy Deliberation Committee - 건강보험정책심의위원회] and the DREC [Drug Benefit Evaluation Committee -약제급여평가위원], and we play a role in gathering and conveying the views of patients to these bodies. | Santé générale
> Prestation de soins de santé | Partenariat réglementaire
> Participer aux évaluations des technologies de santé (ETS) et aux examens de remboursement | 100 000 | National | Regularly | 115009387424 |
| Regular roundtables and forums are being held with the Ministry of Health and Welfare, the NHIS [국민건강보험공단 – National Health Insurance Service], HIRA [건강보험심사평가원 – Health Insurance Review and Assessment Service], the Korea Medical Research Institute, and other relevant bodies, with a view to improving the pharmaceutical pricing system. | Cancer
> Cancer : la plupart des types | Partenariat réglementaire
> Assister/faciliter des réunions avec des décideurs politiques/régulateurs | 10 000 | National | Regularly | 114998266569 |
| Attendance at relevant committee meetings and informal consultative sessions. | Congénital
> Congénital : cœur | Partenariat réglementaire
> Assister/faciliter des réunions avec des décideurs politiques/régulateurs | 10 000 | National | Rarely | 115003445044 |
| Activities include policy forums, stakeholder consultations, meetings with relevant government ministries, and related engagements. | Rare
> Maladies rares : la plupart des types | Partenariat réglementaire
> Assister/faciliter des réunions avec des décideurs politiques/régulateurs | 1 000 | National | Regularly | 115033450975 |
| Convening public hearings in the National Assembly and submitting formal recommendations to the Ministry of Health and Welfare [in Korea]. | Santé mentale
> Santé mentale : la plupart des affections | Influencer les politiques et la législation
> Influencer les politiques et la législation en matière de santé | 5 000 | Regional | Sometimes | 115019561629 |
| Activities included participation in policy forums advocating for the reimbursement of treatments currently excluded from public health insurance coverage, including Durvalumab and the graft-versus-host disease treatment Belumosudil. | Cancer
> Cancer : sang | Influencer les politiques et la législation
> Participer aux audiences publiques et aux consultations | 100 000 | Regional | Sometimes | 115008918207 |
| Convening of National Assembly public hearings. | Santé mentale
> Santé mentale : la plupart des affections | Influencer les politiques et la législation
> Participer aux audiences publiques et aux consultations | 5 000 | Regional | Sometimes | 115019561629 |
| We engage in these activities [involvement with drug-pricing regulators] when seeking reimbursement coverage for new medicines, as well as at forums and panel discussions. | Cancer
> Cancer : sang | Influencer les politiques et la législation
> Participer aux audiences publiques et aux consultations | 1 000 | Regional | Sometimes | 115028455157 |
| Activities include participation in forums and debates, submission of petitions to the 인권위 [국가인권위원회 – National Human Rights Commission]. | Défense des droits des patients
> Droits du patient | Influencer les politiques et la législation
> Participer aux audiences publiques et aux consultations | 5 000 | Regional | Regularly | 115033350867 |
| Participated in a National Assembly policy forum on medicines not covered by public health insurance to convey the patient perspective. | Cancer
> Cancer : sein | Influencer les politiques et la législation
> Participer aux audiences publiques et aux consultations | 5 000 | National | Sometimes | 115058944486 |
| A request for the re-listing of a Parkinson's disease treatment. | Neurodégénératif
> Parkinson | Influencer les politiques et la législation
> Traitement des obstacles/anomalies dans les soins médicaux | 5 000 | National | Rarely | 115055431165 |
| Regular roundtables and forums are being held with the Ministry of Health and Welfare, the NHIS [국민건강보험공단 – National Health Insurance Service], HIRA [건강보험심사평가원 – Health Insurance Review and Assessment Service], the Korea Medical Research Institute, and other relevant bodies, with a view to improving the pharmaceutical pricing system. | Cancer
> Cancer : la plupart des types | Plaidoyer pour la tarification et l'accessibilité financière
> Plaider pour une tarification équitable des médicaments | 10 000 | National | Regularly | 114998266569 |
| Participated in a National Assembly policy debate on non-reimbursable drugs to convey patients' voices, and engaged in a petition drive to advocate for reimbursement coverage. | Cancer
> Cancer : sein | Plaidoyer pour la tarification et l'accessibilité financière
> Plaider pour une tarification équitable des médicaments | 5 000 | National | Sometimes | 115058944486 |
| We assess cost-effectiveness. | Foie
> Maladies du foie : la plupart des types | Plaidoyer pour la tarification et l'accessibilité financière
> Participer aux négociations du comité d'examen des prix | 100 000 | National | Sometimes | 114998327089 |
| We engage in these activities [involvement with drug-pricing regulators] when seeking reimbursement coverage for new medicines, as well as at forums and panel discussions. | Cancer
> Cancer : sang | Plaidoyer pour la tarification et l'accessibilité financière
> Participer aux négociations du comité d'examen des prix | 1 000 | Regional | Sometimes | 115028455157 |
| Reimbursement rates for basic welfare recipients. | Santé mentale
> Santé mentale : la plupart des affections | Plaidoyer pour la tarification et l'accessibilité financière
> Réduire les obstacles financiers pour les personnes à faibles revenus et les personnes vulnérables | 5 000 | Regional | Sometimes | 115021952415 |
| Inclusion of medical devices — such as continuous glucose monitors and insulin pumps — on the national health insurance formulary. | Endocrinien
> Diabète : type 1 | Plaidoyer pour la tarification et l'accessibilité financière
> Plaidoyer pour l'inclusion du produit dans les listes de remboursement/formulaires nationaux | 100 000 | National | No | 114998267322 |
| Activities included participation in policy forums advocating for the reimbursement of treatments currently excluded from public health insurance coverage, including Durvalumab [help the body's immune system recognize and destroy cancer] and the graft-versus-host disease treatment Belumosudil. | Cancer
> Cancer : sang | Plaidoyer pour la tarification et l'accessibilité financière
> Plaidoyer pour l'inclusion du produit dans les listes de remboursement/formulaires nationaux | 100 000 | Regional | Sometimes | 115008918207 |
| We engage in these activities [involvement with drug-pricing regulators] when seeking reimbursement coverage for new medicines, as well as at forums and panel discussions. | Cancer
> Cancer : sang | Plaidoyer pour la tarification et l'accessibilité financière
> Plaidoyer pour l'inclusion du produit dans les listes de remboursement/formulaires nationaux | 1 000 | Regional | Sometimes | 115028455157 |
| Participated in a National Assembly policy debate on non-reimbursable drugs to convey patients' voices, and engaged in a petition drive to advocate for reimbursement coverage. | Cancer
> Cancer : sein | Plaidoyer pour la tarification et l'accessibilité financière
> Plaidoyer pour l'inclusion du produit dans les listes de remboursement/formulaires nationaux | 5 000 | National | Sometimes | 115058944486 |
| A request for the re-listing of a Parkinson's disease treatment. | Neurodégénératif
> Parkinson | Amélioration des voies d'accès
> Faciliter l'accès équitable aux médicaments/soins de santé | 5 000 | National | Rarely | 115055431165 |
| We nominate patient group representatives as committee members on bodies such as the HIPDC [Health Insurance Policy Deliberation Committee - 건강보험정책심의위원회] and the DREC [Drug Benefit Evaluation Committee -약제급여평가위원], and we play a role in gathering and conveying the views of patients to these bodies. | Santé générale
> Prestation de soins de santé | Contribution des patients fondée sur des données probantes
> Utilisez les informations sur les patients pour éclairer les décisions | 100 000 | National | Regularly | 115009387424 |
| We submit written recommendations on a regular basis. | Cancer
> Cancer : sang | Contribution des patients fondée sur des données probantes
> Utilisez les informations sur les patients pour éclairer les décisions | 10 000 | National | Regularly | 115056090120 |
| Participated in a National Assembly policy forum on medicines not covered by public health insurance to convey the patient perspective. | Cancer
> Cancer : sein | Contribution des patients fondée sur des données probantes
> Utilisez les informations sur les patients pour éclairer les décisions | 5 000 | National | Sometimes | 115058944486 |
| We submit written recommendations on a regular basis. | Cancer
> Cancer : sang | Contribution des patients fondée sur des données probantes
> Traduire les preuves et les informations en contributions politiques | 10 000 | National | Regularly | 115056090120 |
| Attendance at relevant committee meetings and informal consultative sessions. | Congénital
> Congénital : cœur | Gouvernance institutionnelle
> Assurer la représentation au sein des organes consultatifs gouvernementaux | 10 000 | National | Rarely | 115003445044 |
| We nominate patient group representatives as committee members on bodies such as the HIPDC [Health Insurance Policy Deliberation Committee - 건강보험정책심의위원회] and the DREC [Drug Benefit Evaluation Committee -약제급여평가위원], and we play a role in gathering and conveying the views of patients to these bodies. | Santé générale
> Prestation de soins de santé | Gouvernance institutionnelle
> Assurer la représentation au sein des organes consultatifs gouvernementaux | 100 000 | National | Regularly | 115009387424 |
| Activities include participation in forums and debates, submission of petitions to the 인권위 [국가인권위원회 – National Human Rights Commission]. | Défense des droits des patients
> Droits du patient | Défense des droits des patients/amélioration de la qualité de vie
> Protéger/améliorer l'expérience du patient | 5 000 | Regional | Regularly | 115033350867 |
interactions
actions et plaidoyer
7 mentions
